![Frédéric Grégoire René Sedel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frédéric Grégoire René Sedel
Oprichter bij
MedDay Pharmaceuticals SAS
Health Technology
Profiel
Frédéric Grégoire René Sedel is the founder of MedDay Pharmaceuticals SA, founded in 2011, where the title held is Chief Scientific Officer & Director since 2018.
The current job is General Manager & Chief Medical Officer at OTR3, starting in 2021.
Actieve functies van Frédéric Grégoire René Sedel
| Bedrijven | Functie | Begin |
|---|---|---|
MedDay Pharmaceuticals SAS
 MedDay Pharmaceuticals SAS BiotechnologyHealth Technology Operates as a biotechnology company developing new drugs for nervous system disorders | Oprichter | 29-09-2011 |
OTR3
 OTR3 BiotechnologyHealth Technology Operates biotechnology company | Algemeen Directeur | 01-07-2021 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
7
Eerstegraads connecties
2
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
MedDay Pharmaceuticals SAS
MedDay Pharmaceuticals SAS BiotechnologyHealth Technology Operates as a biotechnology company developing new drugs for nervous system disorders | Health Technology |
OTR3
OTR3 BiotechnologyHealth Technology Operates biotechnology company | Health Technology |
Kies MarketScreener 
